Organization of the human liver carnitine palmitoyltransferase 1 gene (CPT1A) and identification of novel mutations in hypoketotic hypoglycaemia
Stéphanie Gobin(Inserm), Laure Thuillier(Inserm), Jean‐Paul Bonnefont(Inserm), Fatima Djouadi(Délégation Paris 5), M. Ferrec(Hôpital Necker-Enfants Malades), Stephen D. Cederbaum(University of California, Los Angeles), A. J. Green(Birmingham Children's Hospital), Hidayeth Rostane(Hôpital Necker-Enfants Malades), Jean‐Marie Saudubray(Sorbonne Université), Claude Mugnier(Inserm), George F. Gray(NewYork–Presbyterian Hospital), France Demaugre(Inserm), William L. Nyhan(University of California San Diego), Richard Haas(University of California San Diego), Carina Prip‐Buus(Centre National de la Recherche Scientifique), Jean Girard(Centre National de la Recherche Scientifique), William R. Wilcox(Emory University)
Cited by 53
Related Papers
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
|Genetics in Medicine|2014|605
Agalsidase-Beta Therapy for Advanced Fabry Disease
|Annals of Internal Medicine|2007|565
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.
|Journal of Clinical Investigation|1998|406
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
|Nephrology Dialysis Transplantation|2009|366